Piedmont Investment Advisors’s West Pharmaceutical WST Stock Holding History

Piedmont Investment Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,409	Closed	-$1.58M	–	702
2020 Q1	$1.58M	Buy	10,409 +733	+8%	+$113K	0.06%	237
2019 Q4	$1.46M	Sell	9,676 -1,008	-9%	-$147K	0.05%	251
2019 Q3	$1.51M	Sell	10,684 -475	-4%	-$65.4K	0.06%	238
2019 Q2	$1.4M	Buy	11,159 +7,970	+250%	+$941K	0.06%	256
2019 Q1	$351K	Sell	3,189 -5	-0.2%	-$520	0.01%	722
2018 Q4	$313K	Buy	+3,194	New	+$347K	0.01%	690
2018 Q3	–	Sell	-22	Closed	-$2K	–	2297
2018 Q2	$2K	Buy	+22	New	+$2.02K	﹤0.01%	2648

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Piedmont Investment Advisors's WST Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of West Pharmaceutical (WST) in Q2 2020, closing a stake of 10,409 shares — an estimated $1.58M sold.

Piedmont Investment Advisors first reported a position in WST in Q2 2018 and held it in 7 quarters. The position peaked at $1.58M in Q1 2020. 523 funds tracked by Wall St. Rank hold WST as of Q2 2020.

Piedmont Investment Advisors reported no remaining West Pharmaceutical position as of Q2 2020 after selling out during the quarter.
Piedmont Investment Advisors sold 10,409 West Pharmaceutical shares in Q2 2020, an estimated $1.58M.
Piedmont Investment Advisors first reported a position in West Pharmaceutical in Q2 2018 and held it in 7 quarters.
Piedmont Investment Advisors's West Pharmaceutical position peaked at $1.58M in Q1 2020.
523 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.